The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis …

C Roubille, V Richer, T Starnino, C McCourt… - Annals of the …, 2015 - ard.bmj.com
The objective of this systematic literature review was to determine the association between
cardiovascular events (CVEs) and antirheumatic drugs in rheumatoid arthritis (RA) and …

Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review

C Roubille, B Haraoui - Seminars in arthritis and rheumatism, 2014 - Elsevier
Objective To review published cases of induced or exacerbated interstitial lung disease (ILD)
in rheumatoid arthritis (RA) associated with non-biologic disease-modifying antirheumatic …

Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation

…, O Hermine, A Rigolet, C Roubille… - Blood, The Journal …, 2014 - ashpublications.org
Histiocytoses are a group of heterogeneous diseases that mostly comprise Langerhans cell
histiocytosis (LCH) and non-LCH. The association of LCH with non-LCH is exceptional. We …

Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: expert opinion of the Canadian …

C Roubille, V Richer, T Starnino, C McCourt… - The Journal of …, 2015 - jrheum.org
Objective. Comorbidities such as cardiovascular diseases (CVD), cancer, osteoporosis, and
depression are often underrecognized in patients with rheumatoid arthritis (RA), psoriatic …

First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative …

J Martel-Pelletier, C Roubille, F Abram… - Annals of the …, 2015 - ard.bmj.com
Objective To determine, using data from participants enrolled in the progression cohort of the
OAI, the effects of conventional osteoarthritis (OA) pharmacological treatment and those of …

Disease-modifying effect of strontium ranelate in a subset of patients from the Phase III knee osteoarthritis study SEKOIA using quantitative MRI: reduction in bone …

JP Pelletier, C Roubille, JP Raynauld… - Annals of the …, 2015 - ard.bmj.com
Objective To explore, using MRI, the disease-modifying effect of strontium ranelate (SrRan)
treatment on cartilage volume loss (CVL) and bone marrow lesions (BMLs) in a subset of …

[HTML][HTML] Convalescent plasma for persisting COVID‐19 following therapeutic lymphocyte depletion: a report of rapid recovery

…, G Cartron, E Tchernonog, C Roubille… - British journal of …, 2020 - ncbi.nlm.nih.gov
Discussion To date, treatment of COVID-19 is still challenging and there is no specific
recommended therapy. Despite the sequential introduction of different treatments, our patient …

Persistence of neutrophil extracellular traps and anticardiolipin auto‐antibodies in post‐acute phase COVID‐19 patients

…, A Kudriavtsev, M Berger, C Roubille… - Journal of Medical …, 2023 - Wiley Online Library
In the early phase of the pandemic, we were among the first to postulate that neutrophil
extracellular traps (NETs) play a key role in COVID‐19 pathogenesis. This exploratory …

Seven-year tolerability profile of glucocorticoids use in early rheumatoid arthritis: data from the ESPOIR cohort

C Roubille, N Rincheval, M Dougados… - Annals of the …, 2017 - ard.bmj.com
Objective To explore the 7-year tolerability profile of glucocorticoids (GC) for early rheumatoid
arthritis (RA). Methods We examined data for 602 patients with RA from the early arthritis …

Psoriasis and smoking: a systematic literature review and meta-analysis with qualitative analysis of effect of smoking on psoriasis severity

V Richer, C Roubille, P Fleming… - Journal of …, 2016 - journals.sagepub.com
Background: Smoking has been associated with psoriasis prevalence and severity.
Objective: To evaluate prevalence of smoking in patients with psoriasis and to examine the …